Sagi 2000 Industrial Park, P.O. Box 6

Migdal Haemeq




Tel. + 972 74 717 7177

Fax. + 972 74 717 7001


Essential Oils, Oleoresins and Plant Extracts


Who We Are

Enzymotec develops and manufactures nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies. Since its establishment in 1998, the company has enjoyed accelerated growth, generating impressive sales worldwide, by launching a diverse portfolio of innovative products. Our two business segments leverage our lipid-related expertise: Nutrition and Pharma.

Enzymotec's diverse range of products span the entire human life-cycle - from infancy to old age, providing key ingredients for use in infant formula and nutritional supplements, as well as branded medical foods.

Enzymotec's multi-disciplinary team, including scientists, engineers and business development professionals, have an outstanding track-record in turning advanced lipid science into commercially attractive, nutritional solutions, constantly enriching our unique cluster of technology and expertise.

What We Do

We develop clinically-validated products including bio-functional, lipid-based compounds that address a wide spectrum of growing consumer demands, such as optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases.

The comprehensive solutions we develop and manufacture are sold to major consumer companies through our global sales and marketing infrastructure.

How We Do It

We employ proprietary technologies to modify lipids harvested from natural sources, transforming these raw materials into unique and clinically-proven lipid based products. These products are familiar to the human body and possess beneficial secondary characteristics, such as extended shelf life and improved scent or taste profile.

Our Source of Competitive Advantage:

• Safe and clinically-proven products supported by proprietary technology and R&D expertise.

• Experienced leadership and scientific advisory boards.

• Diversified business model

• Strong customer relationships and partnerships

• Integrated scalable platform and product offering, based on state-of-the-art production capabilities.

Articles On FoodIngredientsFirst


Food Ingredients News  24 August 2017

Frutarom moves for full control of Enzymotec

24 Aug 2017 --- Frutarom has announced that it has acquired from Paulson & Co. Inc., Enzymotec’s largest shareholder, approximately 9.2 percent of the ordinary shares of Enzymotec Ltd. for an aggregate amount of approximately US$24.2 million, reflecting a purchase price of US$11.5 per share and intends to make a tender offer for the entire company at the same price. 

Food Ingredients News  24 March 2015

Enzymotec Strengthen Its Global Position in the Omega 3 Market

24 Mar 2015 --- Enzymotec, a developer, manufacturer and marketer of innovative bio-active lipid ingredients, has announced that it has been granted patents by the US Patent and Trademark Office and by IP Australia.

Regulatory News  19 May 2014

AAK Initiates Arbitration against Enzymotec About Joint Venture Company

19 May 2014 --- Global specialty oil producer AarhusKarlshamn (AAK), has initiated an arbitration at the International Court of Arbitration (ICC), against bio-active lipid ingredient manufacturer Enzymotec. The dispute concerns matters under the Shareholders’ Agreement regarding the joint venture company, Advanced Lipids. The two companies originally entered into this agreement on 14 June 2007.

More Articles

Video Interviews


23 June 2016

New Platforms for PS Beyond Cognitive Health

23 Jun 2016 --- Enzymotec Nutrition segment develops and manufactures lipid-based ingredients. These biofunctional compounds are used for various applications such as infant formula, nutritional supplements and other dietary needs. Enzymotecs’ line of cognitive products is based on phosphatidylserine (PS) which is one of the most researched ingredients shown to be potent in affecting cognitive activity.